The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...
The Alberta Energy Regulator (AER) has fined an Edmonton company $303,769 for contravening an environmental protection order ...
We recently published a list of 15 Best Fast Growth Stocks To Buy Right Now. In this article, we are going to take a look at ...
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Highlights,Sarepta Therapeutics continues to expand its RNA-targeted and gene therapy treatments for rare ...
William Blair analyst Sami Corwin maintained a Hold rating on BioMarin Pharmaceutical (BMRN – Research Report) today. The company’s shares ...
Arrowhead Pharmaceuticals stock could remain under pressure in the near-term, but improved financial outlook and pipeline ...
Shares of biotech company Solid Biosciences (NASDAQ: SLDB) skyrocketed on Feb. 18 after the firm released key clinical data.
The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...
Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results